SEC Company Response from Viela Bio, Inc. (CIK 0001734517) — May 26, 2020
Viela Bio, Inc. (CIK 0001734517)
Date: May 26, 2020 · CIK: 0001734517 · Accession: 0001193125-20-150849
AI Filing Summary & Sentiment
File numbers found in text: 333-238678
Letter
May 26, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, D.C. 20549-3561
Attn:
Suzanne Hayes, Office of Healthcare & Insurance
Re:
Viela Bio, Inc.
Registration Statement on Form S-1 (File No. 333-238678)
Ladies and Gentleman:
In connection with the above-referenced Registration Statement and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Viela Bio, Inc. that the effectiveness of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern time, on Wednesday, May 27, 2020, or as soon as practicable thereafter.
Pursuant to Rule 460 of the General Rules and Regulations under the Act, please be advised that there will be distributed to each underwriter or dealer who is reasonably anticipated to participate in the distribution of the security as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned further advise that they have complied with and will continue to comply, and that they have been informed that the other prospective underwriters have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of page intentionally left blank]
Very truly yours,
MORGAN STANLEY & CO. LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 26, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549-3561 Attn: Suzanne Hayes, Office of Healthcare & Insurance Re: Viela Bio, Inc. Registration Statement on Form S-1 (File No. 333-238678) Ladies and Gentleman: In connection with the above-referenced Registration Statement and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Viela Bio, Inc. that the effectiveness of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern time, on Wednesday, May 27, 2020, or as soon as practicable thereafter. Pursuant to Rule 460 of the General Rules and Regulations under the Act, please be advised that there will be distributed to each underwriter or dealer who is reasonably anticipated to participate in the distribution of the security as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned further advise that they have complied with and will continue to comply, and that they have been informed that the other prospective underwriters have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Remainder of page intentionally left blank] Very truly yours, MORGAN STANLEY & CO. LLC GOLDMAN SACHS & CO. LLC COWEN AND COMPANY, LLC As representatives of the several underwriters MORGAN STANLEY & CO. LLC By: /s/ Chris Rigoli Name: Chris Rigoli Title: Vice President GOLDMAN SACHS & CO. LLC By: /s/ Amit Sinha Name: Amit Sinha Title: Managing Director COWEN AND COMPANY, LLC By: /s/ Bill Follis Name: Bill Follis Title: Managing Director